Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BRFS
526
DELISTED
BRF SA
BRFS
| $31.1M | 0.04% |
8,520,760
+441,290
| +5% | +$1.6M |
2023 Q1
9 quarters
|
|
527
Warby Parker
WRBY
$3.08B
| $31.1M | 0.04% |
1,417,300
-320,200
| -18% | -$5.92M |
2023 Q1
9 quarters
|
|
528
Insmed
INSM
$21.9B
| $31.1M | 0.04% |
+308,687
| New | +$23.6M |
2025 Q2
0 quarters
|
|
529
Avery Dennison
AVY
$12.7B
| $31M | 0.04% |
176,700
+16,000
| +10% | +$2.8M |
2024 Q4
2 quarters
|
|
530
State Street Financial Select Sector SPDR ETF
XLF
$50.7B
| $30.9M | 0.04% |
589,110
+352,400
| +149% | +$17.4M |
2024 Q4
2 quarters
|
|
531
Vital Farms
VITL
$405M
| $30.7M | 0.04% |
797,754
+38,500
| +5% | +$1.3M |
2021 Q2
16 quarters
|
|
532
Builders FirstSource
BLDR
$5.79B
| $30.6M | 0.04% |
+262,341
| New | +$30.3M |
2025 Q2
0 quarters
|
|
533
State Street Industrial Select Sector SPDR ETF
XLI
$30.1B
| $30.5M | 0.04% |
+206,600
| New | +$28.2M |
2025 Q2
0 quarters
|
|
534
Bio-Techne
TECH
$11.4B
| $30.4M | 0.04% |
590,700
+446,300
| +309% | +$22.4M |
2025 Q1
1 quarter
|
|
535
Millicom
TIGO
$14.8B
| $30.4M | 0.04% |
810,634
+664,434
| +454% | +$22.8M |
2019 Q2
24 quarters
|
|
536
Melco Resorts & Entertainment
MLCO
$1.59B
| $30.2M | 0.04% |
4,175,400
+1,336,100
| +47% | +$7.77M |
2023 Q2
8 quarters
|
|
537
American Healthcare REIT
AHR
$11B
| $30.2M | 0.04% |
821,600
+322,500
| +65% | +$10.7M |
2024 Q2
4 quarters
|
|
538
Arm
ARM
$294B
| $30.2M | 0.04% |
186,600
+167,100
| +857% | +$20.7M |
2025 Q1
1 quarter
|
|
539
Chord Energy
CHRD
$7.79B
| $30.1M | 0.04% |
311,216
-244,100
| -44% | -$23.2M |
2024 Q1
5 quarters
|
|
|
TGB
540
Trekor Metals
TGB
$3.04B
| $30.1M | 0.04% |
9,539,887
+2,662,217
| +39% | +$6.23M |
2013 Q2
48 quarters
|
|
541
Gerdau
GGB
$9.65B
| $29.9M | 0.04% |
10,243,601
+1,857,577
| +22% | +$5.09M |
2024 Q2
4 quarters
|
|
542
Eastman Chemical
EMN
$7.29B
| $29.8M | 0.04% |
398,540
-190,100
| -32% | -$14.9M |
2024 Q3
3 quarters
|
|
543
Sabra Healthcare REIT
SBRA
$4.81B
| $29.7M | 0.04% |
1,612,120
+190,200
| +13% | +$3.38M |
2023 Q3
7 quarters
|
|
544
VF Corp
VFC
$5.71B
| $29.7M | 0.04% |
2,528,200
+768,305
| +44% | +$9.52M |
2022 Q1
13 quarters
|
|
545
Aecom
ACM
$7.65B
| $29.7M | 0.04% |
262,727
-83,650
| -24% | -$8.68M |
2023 Q3
7 quarters
|
|
546
Coeur Mining
CDE
$17.3B
| $29.6M | 0.04% |
+3,338,289
| New | +$24.3M |
2025 Q2
0 quarters
|
|
547
Barrett Business Services
BBSI
$780M
| $29.6M | 0.04% |
709,400
-17,200
| -2% | -$708K |
2013 Q2
48 quarters
|
|
548
DHT Holdings
DHT
$4.02B
| $29.5M | 0.04% |
2,732,645
+82,600
| +3% | +$911K |
2017 Q1
33 quarters
|
|
549
iRadimed
IRMD
$1.1B
| $29.4M | 0.04% |
491,812
-9,900
| -2% | -$543K |
2017 Q3
31 quarters
|
|
550
Jefferies Financial Group
JEF
$10.2B
| $29.4M | 0.04% |
537,589
-140,848
| -21% | -$6.97M |
2025 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.